We are live on
!
Find out more
NMC
NEA Management Company Portfolio holdings
AUM
$1.76B
1-Year Est. Return
223.33%
This Fund
S&P 500
This Quarter
Est. Return
+22.64%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.33B
AUM Growth
+$30M
(+2.3%)
Cap. Flow
-$140M
Cap. Flow
% of AUM
-10.53%
Top 10 Holdings %
Top 10 Hldgs %
81.33%
Holding
38
New
1
Increased
4
Reduced
2
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oric Pharmaceuticals
ORIC
|
+$12.9M |
| 2 |
Trevi Therapeutics
TRVI
|
+$11.5M |
| 3 |
Celcuity
CELC
|
+$11.4M |
| 4 |
OMDA
Omada Health Inc
OMDA
|
+$6.3M |
| 5 |
ZBIO
Zenas BioPharma
ZBIO
|
+$1.17M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TEM
Tempus AI
TEM
|
+$126M |
| 2 |
VRNA
Verona Pharma
VRNA
|
+$31.5M |
| 3 |
RGLS
Regulus Therapeutics
RGLS
|
+$11.3M |
| 4 |
DM
Desktop Metal, Inc.
DM
|
+$7.07M |
| 5 |
BuzzFeed
BZFD
|
+$5.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 91.51% |
| 2 | Consumer Staples | 8.49% |
| 3 | Industrials | 0.01% |
| 4 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ADAP
26
DELISTED
Adaptimmune Therapeutics
ADAP
| $4.09M | 0.31% |
17,079,778
| – | – |
|
|
SYBX
27
DELISTED
Synlogic
SYBX
| $3.71M | 0.28% |
2,922,772
| – | – |
|
28
Marker Therapeutics
MRKR
$18.8M
| $2.49M | 0.19% |
1,625,678
| – | – |
|
|
OKUR
29
OnKure Therapeutics
OKUR
$160M
| $1.14M | 0.09% |
478,548
| – | – |
|
30
X4 Pharmaceuticals
XFOR
$390M
| $949K | 0.07% |
499,559
-1
| -0% | -$4 |
|
|
IMA
31
ImageneBio Inc
IMA
$61.4M
| $804K | 0.06% |
50,005
| – | – |
|
32
Wheels Up
UP
$197M
| $114K | 0.01% |
5,306
| – | – |
|
|
AFMD
33
DELISTED
Affimed
AFMD
| – | – |
-442,648
| Closed | -$320K |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| – | – |
-6,147,260
| Closed | -$1.4M |
|
|
35
BuzzFeed
BZFD
$91.6M
| – | – |
-2,512,103
| Closed | -$5.35M |
|
|
RGLS
36
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-6,467,802
| Closed | -$11.3M |
|
|
TEM
37
Tempus AI
TEM
$8.39B
| – | – |
-2,615,979
| Closed | -$126M |
|
|
DM
38
DELISTED
Desktop Metal, Inc.
DM
| – | – |
-1,439,892
| Closed | -$7.07M |
|
Similar funds
NM
SLF
SW
CGH
PWP
CIP
GD
DF
NEA Management Company's Q2 2025 Portfolio in Review
As of Q2 2025, NEA Management Company held 38 positions worth $1.33B, up 2.3% from $1.3B the previous quarter. Its ten largest holdings account for 81% of the portfolio.
NEA Management Company withdrew a net $140M in Q2 2025, closing 6 positions and reducing 2 holdings. Its most notable exit was Tempus AI, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 92% a quarter earlier, followed by Consumer Staples and Industrials.
Against the trend, NEA Management Company opened a new position in Omada Health Inc worth $6.66M.
- NEA Management Company's largest Q2 2025 buy was Omada Health Inc: 364,115 shares worth $6.66M.
- NEA Management Company added most to Oric Pharmaceuticals in Q2 2025, an estimated $12.9M increase.
- NEA Management Company's biggest Q2 2025 reduction was Verona Pharma, cutting an estimated $31.5M.
- NEA Management Company fully exited Tempus AI in Q2 2025, selling an estimated $126M.
- NEA Management Company's ten largest holdings make up 81% of its $1.33B portfolio in Q2 2025.
- NEA Management Company opened 1 new position and closed 6 in Q2 2025.
- NEA Management Company's portfolio value rose 2.3% quarter-over-quarter to $1.33B.
Based on NEA Management Company's 13F filing for Q2 2025, filed 14 Aug 2025.